I båda studierna, var det totalt sett mindre sannolikt att de patienter som fick IntronA plus ribavirin svarade än de som fick pegylerat interferon alfa- 2b med ribavirin. ###>Overall, in both studies, patients who received IntronA plus ribavirin, were less likely to respond than patients who received pegylated interferon alfa-2b with ribavirin.